Found 70 matching trials
A PK and Salvage Study for Children With HIV-infection PHASE4 To evaluate the pharmacokinetics (PK) of LPV/r with saquinavir in HIV-1 inf...
Show More Location
Chulalongkorn University Hospital, Department of Pediatrics
Learn More & Join Trial
Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children PHASE2 A two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating s...
Show More Location
Hospital Garrahan
Learn More & Join Trial
Research In Viral Eradication of HIV Reservoirs PHASE2 This study will be a two-arm prospective 1:1 randomised controlled trial co...
Show More Location
Brighton and Sussex University Hospitals NHS Trust
Learn More & Join Trial
Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG) PHASE4 The purpose of the study is to investigate the benefits of switching away f...
Show More Location
Insititute Of Tropical Medicine Antwerp
Learn More & Join Trial
Switching From PI to RALtegravir in HIV Stable Patients PHASE3 The investigators hypothesis is that switching from a ritonavir-boosted PI ...
Show More Learn More & Join Trial
PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial PHASE4 BACKGROUND: Since 1996 the combination of three or more drugs has been the ...
Show More Location
Centro de Tratamento Ambulatoria do Hospital Nacional Simão Mendes
Learn More & Join Trial
MARCH Central Nervous System Substudy N/A This substudy is a prospective, observational, open-label, randomised study...
Show More Learn More & Join Trial
Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD N/A Tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) is being used m...
Show More Location
Les Centres GHESKIO CRS (30022)
Learn More & Join Trial
Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals EARLY_PHASE1 To find out if it is possible for HIV-1 patients to maintain antiretroviral...
Show More Location
The Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients PHASE3 This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...
Show More Location
Spectrum Medical Group
Learn More & Join Trial